If you searched for fraboc, the term most clearly refers to FRA-BOC, or Familial Risk Assessment, Breast and Ovarian Cancer. It was an Australian online clinical tool designed for healthcare professionals to assess a patient’s risk of developing breast or ovarian cancer using family history. Cancer Australia now classifies FRA-BOC as a former tool and says it is no longer available on its website.
That distinction matters because Fraboc was not a cancer diagnosis, genetic test, or treatment. Its purpose was risk assessment. It helped health professionals interpret patterns in a person’s family history and determine whether further assessment or specialist care might be appropriate.
Today, newer risk assessment tools are used instead, including iPrevent for breast cancer risk assessment.
What does Fraboc mean?
Fraboc is commonly used as a simplified spelling of FRA-BOC, which stands for:
Familial Risk Assessment, Breast and Ovarian Cancer
The name describes exactly what the former tool was intended to do. It provided a structured way for health professionals to assess breast and ovarian cancer risk associated with family history.
Cancer Australia describes FRA-BOC as an online tool designed for health professionals such as general practitioners and nurses.
The term may appear in several forms, including:
- Fraboc
- FRABOC
- FRA-BOC
- Familial Risk Assessment, Breast and Ovarian Cancer
- Familial Risk Assessment for breast and ovarian cancer
These variations can refer to the same historical Australian clinical resource.
What was Fraboc used for?
FRA-BOC was designed to help healthcare professionals assess cancer risk when family history raised questions about a patient’s likelihood of developing breast or ovarian cancer.
Family history can provide important clues. Relevant information may include:
- Which relatives had cancer
- Whether affected relatives were on the same side of the family
- The type of cancer diagnosed
- The age at which relatives developed cancer
- Whether multiple relatives were affected
- Whether breast and ovarian cancers occurred within the same family
The broader principle remains relevant today. Cancer Australia notes that the significance of a breast cancer family history generally increases when more relatives are affected and when cancers occur at younger ages.
The purpose of this type of assessment is not to predict the future with certainty. Instead, it helps determine whether someone’s family history suggests population level risk, increased risk, or a need for more detailed evaluation.
Was Fraboc a cancer test?
No. Fraboc was not a cancer diagnostic test.
It was a risk assessment tool.
That distinction is important. A risk assessment considers factors that may make cancer more or less likely. A diagnostic test is used to determine whether a disease is currently present.
FRA-BOC was also not a genetic test. Genetic testing can sometimes be appropriate for people whose personal or family history suggests a possible inherited cancer predisposition, but that is a separate clinical process.
Cancer Australia explains that some women with a strong family history may be referred to a family cancer clinic for more precise risk assessment, advice about genetic testing, and an individualized management plan.
Who used the FRA-BOC tool?
The original tool was intended for health professionals, rather than for people to diagnose themselves.
Cancer Australia specifically identifies general practitioners and nurses among the intended professional users.
That is useful context if you have found the term in an older medical record, referral document, professional resource, or Australian healthcare publication. Seeing FRA-BOC in such material does not mean that the person had cancer. It indicates that a familial cancer risk assessment was being discussed or performed.
What information did Fraboc consider?
The central issue was family history.
A useful family history for cancer risk assessment can involve much more than simply asking whether a parent had cancer. The pattern can matter.
For example, healthcare professionals may consider:
| Family history factor | Why it can matter |
| Number of affected relatives | Multiple affected relatives can indicate a stronger familial pattern |
| Degree of relationship | Affected close relatives generally provide more relevant information |
| Age at diagnosis | Younger diagnoses can be more significant in familial risk assessment |
| Cancer type | Breast and ovarian cancers can be relevant to inherited cancer risk |
| Side of the family | Maternal and paternal family histories both matter |
| Multiple cancer diagnoses | Certain combinations can raise additional questions |
| Bilateral breast cancer | Cancer affecting both breasts can be relevant to risk assessment |
| Male breast cancer | A male relative with breast cancer can be an important family history feature |
Cancer Australia states that family history from either the mother’s or father’s side can increase breast cancer risk, with significance generally increasing according to the number of affected relatives and their ages at diagnosis.
Does having a family history mean you will develop cancer?
No.
A family history of breast or ovarian cancer does not mean that a person will definitely develop cancer.
Most breast cancers are not explained by inherited genetic changes. Cancer Australia notes that only about 5% of breast cancers can be explained by an inherited gene fault, although family history can still increase an individual’s risk.
Family history can reflect several different things, including inherited genetic factors, shared environmental influences, shared lifestyle factors, or simply the occurrence of a common disease in the same family.
This is why a structured risk assessment can be useful. It helps distinguish a potentially significant familial pattern from a family history that does not substantially change someone’s estimated risk.
Is Fraboc still available?
The original FRA-BOC tool is no longer available through the Cancer Australia website.
Cancer Australia explicitly identifies FRA-BOC as a former tool and directs users toward more up-to-date breast cancer risk assessment resources.
BreastScreen Queensland likewise states that FRA-BOC is no longer available and has been replaced by iPrevent for breast cancer risk assessment.
This means that an old reference to Fraboc should not automatically be interpreted as a recommendation to use the former tool today.
What replaced Fraboc?
For breast cancer risk assessment in Australia, iPrevent is one of the current tools.
Cancer Australia describes iPrevent as a validated breast cancer risk assessment and risk management decision support tool intended to support prevention and screening discussions between women and their doctors.
Current clinical resources also use other validated approaches depending on the person’s circumstances. For example, eviQ identifies tools such as CanRisk and iPrevent for individualized breast cancer risk assessment in relevant clinical situations.
The appropriate tool depends on the clinical question, the person’s family history, known genetic findings, and other risk factors. A newer tool is therefore not simply a modern version of an old calculator that everyone should use in the same way.
How Fraboc relates to genetic testing
FRA-BOC and genetic testing served different purposes.
A familial risk assessment looks at the pattern of cancer within a family and estimates whether that pattern warrants additional evaluation.
Genetic testing looks for particular inherited genetic variants associated with cancer risk.
A person can have a concerning family history without having a known pathogenic genetic variant. Conversely, someone can carry an inherited pathogenic variant even when the family history appears limited.
For people with a sufficiently strong family history, a family cancer clinic or genetics service may provide a more detailed assessment and determine whether genetic testing is appropriate.
Current Australian clinical guidance also recognizes genes such as BRCA1, BRCA2, and PALB2 among the genes relevant to hereditary breast and ovarian cancer risk, although genetic assessment is individualized rather than determined by a single family history detail.
Why might someone still see Fraboc in a medical document?
The simplest explanation is that the document refers to an older Australian clinical resource.
FRA-BOC was used in Australian healthcare guidance before it was retired. Older Cancer Australia material specifically directed health professionals to the FRA-BOC online tool when family history scenarios required more detailed assessment.
You might therefore encounter the term in:
- Older referral letters
- Archived clinical guidelines
- Historical medical records
- Older Australian cancer resources
- Educational material for healthcare professionals
- Previous family cancer risk assessments
The presence of the term does not, by itself, indicate a cancer diagnosis.
Fraboc versus modern risk assessment
The key difference is that Fraboc is now mainly a historical reference, while current clinical practice relies on newer and validated resources.
| Question | FRA-BOC | Current approach |
| Main role | Familial breast and ovarian cancer risk assessment | Individualized cancer risk assessment and management |
| Status | Former tool | Current tools and clinical guidance |
| Intended users | Health professionals | Health professionals and patients working together |
| Cancer diagnosis | No | Risk assessment is still different from diagnosis |
| Genetic test | No | Genetic testing may be considered when clinically appropriate |
| Breast cancer assessment | Historical resource | iPrevent and other validated approaches may be used |
| Family history | Central to assessment | Remains an important risk factor |
The important point is not simply that one tool replaced another. Cancer risk assessment has to be interpreted in clinical context, using current evidence and the individual’s complete history.
What should you do if an old report mentions Fraboc?
If you have found Fraboc in an old medical document, do not assume that the reference represents a current assessment.
Instead, determine what the document was describing and when the assessment was performed.
If the information concerns your current breast or ovarian cancer risk, discuss it with a qualified healthcare professional. Bring the original document if possible. A clinician can consider the historical information alongside your current family history, personal medical history, screening history, and any relevant genetic information.
This is particularly useful if there have been new cancer diagnoses in your family since the original assessment.
Current Cancer Australia guidance notes that people with a strong family history may be referred for more precise assessment and individualized management.
Frequently asked questions about Fraboc
What does Fraboc stand for?
Fraboc commonly refers to FRA-BOC, Familial Risk Assessment, Breast and Ovarian Cancer. It was an Australian online tool for health professionals assessing familial breast and ovarian cancer risk.
Is Fraboc a cancer diagnosis?
No. FRA-BOC was a risk assessment tool, not a diagnostic test.
Is Fraboc a genetic test?
No. It assessed familial cancer risk using family history. Genetic testing is a separate process that may be considered when a person’s history suggests a possible inherited cancer predisposition.
Is Fraboc still available?
No. Cancer Australia says the original FRA-BOC tool is no longer available on its website.
What replaced Fraboc?
For breast cancer risk assessment, BreastScreen Queensland states that FRA-BOC has been replaced by iPrevent. Other validated risk models and clinical resources may also be appropriate depending on the individual situation.
Does having relatives with breast cancer mean I will develop breast cancer?
No. Family history can increase risk, but it does not mean that cancer is certain. Most breast cancers are not caused by inherited genetic changes.
Does the father’s side of the family matter?
Yes. Cancer Australia notes that family history on either the mother’s or father’s side can be relevant to breast cancer risk.
Why would Fraboc appear in an old medical record?
It may appear because the former FRA-BOC tool was previously used in Australian healthcare to assess familial breast and ovarian cancer risk. Older records can therefore contain references to a tool that is no longer available.
The bottom line
Fraboc most clearly refers to FRA-BOC, Familial Risk Assessment, Breast and Ovarian Cancer, a former Australian clinical tool for assessing breast and ovarian cancer risk from family history. It was not a cancer diagnosis and it was not a genetic test.
The original tool is no longer available through Cancer Australia. For current breast cancer risk assessment, newer validated resources such as iPrevent are used, alongside clinical assessment and, when appropriate, genetics services.
If you encounter Fraboc in an older medical document, the most useful interpretation is therefore historical: it refers to an earlier approach to familial cancer risk assessment. For decisions about your current risk, screening, or genetic testing, rely on current clinical guidance rather than treating an old Fraboc assessment as a present-day medical evaluation.
You may also read:Jody morrill wolcott